Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery
Recipient : Salipro Biotech
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The collaboration combines the benefits of Salipro's proprietary platform technology for discovery of small molecule that bind to a membrane protein drug target with DyNAbind’s DNA-Encoded Library technology to accelerate the development of novel drugs...
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 09, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery
Recipient : Salipro Biotech
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?